Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study

Fig. 3

Association between C-reactive protein (CRP) and clinical characteristics. Pie charts showing the distribution of different clinicopatholotgic factors in the elevated CRP and normal CRP, respectively. The Fisher’s exact test was used to compare the difference in the proportion between the two groups. Abbreviations: Number of patients indicated (n); Not statistically significant (ns); Eastern Cooperative Oncology Group (ECOG)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us